In an experiment simulating LPS‐induced sepsis, the use of glutaminase (GLS) blockers reduced survival rates in septic mice and promoted the shift of macrophages towards an M1 inflammatory state by inhibiting GLS activity in a laboratory setting [22]. This evidence concerns the gene GLS and Sepsis.